Form 4 for ETON Eton Pharmaceuticals, Inc.
Accepted 2026-02-05 00:00:00 ET · period of report 2026-02-03 · accession 0001437749-26-003230 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-05 | 2026-02-03 | ETON | RIEDEL NORBERT G | Dir | X - OptEx | $4.42 | +30.0K | 35.0K | +600% | +$132.6K |
| D | 2026-02-05 | 2026-02-03 | ETON | RIEDEL NORBERT G | Dir | X - OptEx | $0.00 | -30.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-03 | X | A | 30,000 | $4.42 | 35,000 | D | — | — | |
| 2 | Derivative | Employee Stock Option (Right to Buy) | 2026-02-03 | X | D | 30,000 | $0.00 | 0 | D | $4.42 · 2025-02-13 to 2034-02-12 | 30,000 Common Stock |